Cutting-edge immunotherapy treatment approved for another deadly cancer

cutting-edge-immunotherapy-treatment-approved-for-another-deadly-cancer

The Food and Drug Administration approved a second version of a groundbreaking treatment Wednesday that genetically alters patients’ cells to attack cancer — this time, to fight aggressive non-Hodgkin lymphoma.

Read more here.


Leave a Reply

Your email address will not be published. Required fields are marked *


Home / Cancer Right / Cutting-edge immunotherapy treatment approved for another deadly cancer